spacer

Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial

Romme Christensen J, Ratzer R, Börnsen L, Lyksborg M, Garde E, Dyrby TB, Siebner HR, Sorensen PS and Sellebjerg F